| |
|
|
|
ImmunoGen Inc.  
|
|
5.98 0.15 (0.03%) |
11-16 16:00 |
|
Open: |
5.78 |
Pre close: |
5.83 |
Target:
|
8.15
|
|
High: |
6.03 |
Low: |
5.7 |
Resistance:
|
6.98
8.05
|
|
Volume: |
1,455,391 |
Market Cap: |
892M |
Support:
|
5.24
4.36
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.71
 |
MACD |
MACD(12,26):
|
-0.49 |
|
MA(20): |
5.84  |
Signal(12,26,9): |
-0.61 |
|
MA(100): |
8.64 |
Stochastic Oscillator |
%K(14,3):
|
43.82 |
|
MA(250): |
9.16 |
%D(3): |
34.65 |
|
Average Volume(K) |
3-Month: |
222083
|
52-Week |
High:
|
13.41 |
|
10-Days: |
226511 |
Low: |
5.24 |
|
RSI |
RSI(14):
|
43.42 |
Change(%): |
4.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.010 |
Return on Equity (ttm) |
435.2 |
Shares Out. (M) |
149.09 |
|
EPS Est. Current Year |
-0.720 |
Return on Assets (ttm) |
-49.6 |
Shares Float (M) |
146.70 |
|
EPS Est. Next Year |
-1.380 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.80 |
|
EPS Est. Next Quarter |
-0.240 |
Qtrly Rev. Growth |
-76.2 |
% Held by Institutions |
44.60 |
|
Forward EPS |
-0.950 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
19.780 |
EBITDA (p.s.) |
-0.066 |
P/E |
-5.92 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.30 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-68.76 |
P/S |
1393059584.00 |
|
Operating Margin |
-147.52 |
Levered Free Cash Flow
(M) |
-72.68 |
P/CF |
-12.97 |
|
|
|
|
|
|
